VPC-14228
CAS No. 19983-28-9
VPC-14228( VPC 14228 | VPC14228 )
Catalog No. M27801 CAS No. 19983-28-9
VPC-14228 is a specific AR-DBD inhibitor that acts by inhibiting both Y594A and Q592A mutants.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 80 | Get Quote |
|
10MG | 131 | Get Quote |
|
25MG | 282 | Get Quote |
|
50MG | 447 | Get Quote |
|
100MG | 624 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameVPC-14228
-
NoteResearch use only, not for human use.
-
Brief DescriptionVPC-14228 is a specific AR-DBD inhibitor that acts by inhibiting both Y594A and Q592A mutants.
-
DescriptionVPC-14228 is a specific AR-DBD inhibitor that acts by inhibiting both Y594A and Q592A mutants.
-
In Vitro——
-
In Vivo——
-
SynonymsVPC 14228 | VPC14228
-
PathwayEndocrinology/Hormones
-
TargetAndrogen Receptor (AR)
-
RecptorIndoleamine 2,3-Dioxygenase (IDO)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number19983-28-9
-
Formula Weight246.33
-
Molecular FormulaC13H14N2OS
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (405.96 mM)
-
SMILESC1CN(CCO1)c1nc(cs1)-c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Shenghua Wu, et al. Indoleamine 2,3-dioxygenase inhibitor, preparation method therefor, and application. WO 2017181849 A1.
molnova catalog
related products
-
LGD-3303
LGD-3303 is an orally available, brain-penetrant nonsteroidal selective androgen receptor modulator (SARM) that that shows little or no cross-reactivity with related nuclear receptors.
-
LY2452473
LY2452473 (TT 701;OPK 88004) is an orally bioavailable selective androgen receptor modulator (SARM) being developed for the treatment of disorders related to hypogonadism.
-
Dehydroepiandrostero...
Dehydroepiandrosterone acetate is a major C19 steroid produced by the adrenal cortex.